Glass House Brands Gains NYSE Listing Approval

LONG BEACH – Glass House Brands Inc. has secured approval to list its shares on the New York Stock Exchange, marking another step for a major player in the state’s market toward a prominent trading venue.

The move follows the company’s earlier restructuring to separate its medical Cannabis operations from its adult-use retail business, a structure designed to meet exchange requirements in the current regulatory environment. Trading under the ticker GLAS is set to begin on June 30, with shares continuing on OTCQX as GLASF until the close on June 29.

Glass House Brands, known for large-scale cultivation in California, applied for the listing after entering agreements to deconsolidate its dual-use operations. A subsidiary retains significant economic interest in the retail side through non-voting units, with voting control held by a third-party investor. Conversion of those units would occur only if the NYSE later allows full consolidation of adult-use activities.

This development comes after Trulieve became the first U.S. Cannabis operator to list on the NYSE, enabled by the federal reclassification of medical Cannabis to Schedule III. Glass House has also positioned itself for potential future opportunities like medical Cannabis exports and interstate commerce between DEA-registered operators.

For the Cannabis sector, particularly in the context of discussions on broader reform, such listings represent incremental progress in gaining access to capital markets. They highlight how regulatory shifts at the federal level can open doors for established players without resolving all underlying state-level issues or federal prohibitions on adult-use activities.

This approval for GHB underscores the practical effects of Schedule III status on corporate strategy. It allows a California-focused operator with substantial cultivation capacity to pursue mainstream exchange visibility while maintaining ties to its retail footprint. The coming months will show how this translates into liquidity, investor interest, and operational execution in a market that continues to reward efficiency and brand strength. Success here could encourage similar moves from peers, though outcomes will hinge on execution amid ongoing state dynamics and any further federal changes.